CDK6 a transcriptional regulator in AML

ASCO 2018 conference round up

Treating CLL with obinutuzumab

First in-human trial of AMV564 for AML

SETBP1 induces transcription of developmental genes

Combination therapy for CLL in the CAPTIVATE trial

Isatuximab in combination to treat relapsed/refractory MM

Single cell profiling reveals key differences in architecture of stem and progenitor cells throughout life

Patient relevant outcomes and advocacy

Development of a risk stratifying prognostic index for ALL

Specification of haematopoetic stem cell fate via modulation of mitochondrial activity

Onset and treatment of infantile leukaemia